- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02069184
IV Acetaminophen for Acute Post Operative Pain in C-Section Patients
August 8, 2019 updated by: Singh Nair, Montefiore Medical Center
Double Blinded Randomized Placebo Controlled Study in Evaluating the Effectiveness of IV Acetaminophen for Acute Post Operative Pain in C-Section Patients
Post-operative pain management after C-section is an important topic as the number of elective c-sections increases each year.
Pain is managed either by giving opioids or by using non-opioids.
The purpose of this study is to evaluate the effectiveness of IV Acetaminophen in pain relief and its impact in the usage of post-operative opioid requirements and opioid associated complications.
The hypothesis is that four doses of IV Acetaminophen in conjunction with intrathecal or epidural morphine given to the patients after c-section will reduce post-operative opioid requirements and opioid associated complications.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Most of the opioids used are centrally acting drugs like morphine or its derivatives.
The most common adverse reactions related to systemic administration of opioids are sedation, itching, constipation and less commonly, respiratory depression.
One of the other management strategies for the pain control is the use of non-steroidal anti-inflammatory drugs (NSAIDS).
Frequent use of NSAIDS is also associated with complications, such as gastric ulcer and platelet dysfunction.
When compared to other non-NSAIDS, IV acetaminophen is a relatively safer drug with quicker onset of action.
In an earlier conducted study, the onset of action of analgesia for a bolus dose of IV acetaminophen is 3 minutes.
IV acetaminophen is FDA approved for management of mild to moderate pain.
An adverse reaction associated with the prolonged usage of IV acetaminophen is hepatic injury.
The most common adverse events encountered during previous clinical trials were nausea, vomiting, headache and insomnia.
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Phase 4
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
New York
-
Bronx, New York, United States, 10467
- Montefiore Medical Center- Weiler
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Elective full term CS patients
- Age 18 and above
- ASA I-III
Exclusion Criteria:
- Allergic reaction to IV acetaminophen
- Not able to understand and sign the research consent
- Pregnancy induced hypertension or pre-eclampsia patients
- Planned intensive care admission patients
- Patients with severe hepatic impairment or active liver diseases (Two fold increase in any of the liver enzymes)
- Patients with serum creatinine>2mg/dl
- For nursing mothers, any evidence of hepatic dysfunction of the new born
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: IV Acetaminophen
IV form, total of 4 doses (each 1000 mg), each every 6th hourly to a maximum dose of 4000 mg in 24 hours.
|
1gm IV. 1st dose at the cord clamping and 3 more doses given every 6th hourly
Other Names:
|
Experimental: Saline as placebo
IV form, total 4 units, each given every 6th hourly in 24 hours.
|
100ml saline IV. 1st dose of 100 ml at cord clamping and 3 more 100ml doses every 6th hourly.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Opioid Requirements in Cesarean Section (C-section) Patient Population
Time Frame: 24 and 48 hours after Cesarean Section
|
24 and 48 hours after Cesarean Section
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Visual Analog Score (VAS) Pain Score
Time Frame: every 6 hours for the first 24 hours after the c-section and there after every 8 hours until the patient is discharged or up to 48 hours
|
Post-operative pain was assessed using VAS pain scores (0-10 scale) with 10 being the worst
|
every 6 hours for the first 24 hours after the c-section and there after every 8 hours until the patient is discharged or up to 48 hours
|
Percentage of Participants Reporting to be Wide Awake up to 72 Hours After the C-section
Time Frame: Percentage of Participants Reporting to be Wide Awake up to 72 hours after the C-section
|
Sedation was assessed on a scale of 1-3 (1= wide awake, 2= sleepy but easily aroused, 3= sleepy and difficult to arouse).
These assessments were made at the same time points as the pain assessments by the same research assistant.
Score 1 is the only good outcome.
|
Percentage of Participants Reporting to be Wide Awake up to 72 hours after the C-section
|
"Percentage of Patients With Adverse Events After the Surgery
Time Frame: every 6 hours for the first 24 hours after the c-section and there after every 8 hours until the patient is discharged or upto 72 hours. Finally, 1 week after discharge.
|
Subjects were specifically asked about adverse events such as nausea, vomiting, pruritus and breathing difficulties and information regarding their bowel movements.
This information was collected on a scale of none, mild, moderate or severe.
These are categorical outcomes.
|
every 6 hours for the first 24 hours after the c-section and there after every 8 hours until the patient is discharged or upto 72 hours. Finally, 1 week after discharge.
|
Number of Participants Using Patient-controlled Analgesia (PCA) Attempts
Time Frame: every 6 hours for the first 24 hours after the c-section and there after every 8 hours until the patient is discharged or upto 72 hours.
|
Data were not collected.The use of patient-controlled analgesia (PCA) pumps could have been utilized to standardize rescue medications.
This would have allowed the collection of the proportion of subjects that required additional rescue medications.
This was another possible endpoint that could have been evaluated.
|
every 6 hours for the first 24 hours after the c-section and there after every 8 hours until the patient is discharged or upto 72 hours.
|
Percentage of Participants That Were Re-Hospitalized 1 Week After Discharge
Time Frame: From time of discharge to 1 week after discharge
|
No patients were re hospitalized in the first 7 days
|
From time of discharge to 1 week after discharge
|
Pain Medication Usage ( NSAIDS)
Time Frame: For the first 24 hours after the c-section until the patient is discharged or up to 48 hours
|
Compare the percentage of patients using non-opioid pain medication at 24 hours, and 48 hours and had experienced any adverse events.
|
For the first 24 hours after the c-section until the patient is discharged or up to 48 hours
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Jeffrey Bernstein, MD, Montefiore Medical Center
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2013
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
December 2, 2013
First Submitted That Met QC Criteria
February 19, 2014
First Posted (Estimate)
February 24, 2014
Study Record Updates
Last Update Posted (Actual)
August 22, 2019
Last Update Submitted That Met QC Criteria
August 8, 2019
Last Verified
August 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-07-144
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-operative Pain
-
Kaohsiung Medical University Chung-Ho Memorial...Not yet recruitingPostoperative Complications | Chronic Post Operative Pain | Acute Post Operative PainTaiwan
-
MercyOne Des Moines Medical CenterTerminatedPost Operative Pain | Post Operative Nausea and VomitingUnited States
-
E-DA HospitalNot yet recruitingCesarean Section | Post Operative Pain, Acute | Post Operative Pain, ChronicTaiwan
-
University of HaifaRecruiting
-
Hospital Universitari Vall d'Hebron Research InstituteRecruitingPost Operative PainSpain
-
Sohag UniversityNot yet recruitingPost Operative Pain
-
Tribhuvan University Teaching Hospital, Institute...Recruiting
-
Beijing Tide Pharmaceutical Co., LtdThe Third Xiangya Hospital of Central South UniversityNot yet recruitingPain, Post-operativeChina
-
Benaroya Research InstituteRecruitingPost Operative PainUnited States
-
National Cancer Institute, EgyptRecruiting
Clinical Trials on IV Acetaminophen
-
MallinckrodtCompletedFever | Acute PainUnited States
-
MallinckrodtCompletedPostoperative Pain | HysterectomyUnited States
-
Massachusetts General HospitalCompletedPain, Postoperative | Infertility, FemaleUnited States
-
TriHealth Inc.Completed
-
MallinckrodtCompleted
-
Nantes University HospitalRecruiting
-
Milton S. Hershey Medical CenterTerminatedStroke | Subarachnoid HemorrhageUnited States
-
McLaren Regional Medical CenterCadence PharmaceuticalsUnknown
-
MallinckrodtCompleted
-
MallinckrodtCompletedPain | FeverUnited States